| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 71,485,887 | 75,203,328 | 54,292,056 | | Cost of Revenue | 46,995,169 | 49,716,267 | 36,627,763 | | | Gross Profit | 24,490,718 | 25,487,062 | 17,664,294 | | | Operating Expenses | | Research Development | 8,413,090 | 8,317,466 | 5,217,826 | | Selling General and Administrative | 9,077,058 | 5,408,489 | 5,285,161 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,000,570 | 11,761,107 | 7,161,307 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 266,433 | 480,165 | 345,919 | | Earnings Before Interest And Taxes | 7,267,004 | 12,241,272 | 7,422,727 | | Interest Expense | 260,795 | 63,335 | 29,047 | | Income Before Tax | 7,006,209 | 12,177,937 | 7,393,680 | | Income Tax Expense | 1,523,886 | 2,241,754 | 1,791,647 | | Minority Interest | 139,560 | 676,061 | (79,218) | | | | Net Income From Continuing Ops | 5,621,884 | 10,612,245 | 5,644,283 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 5,621,884 | 10,612,245 | 5,644,283 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,621,884 | $10,612,245 | $5,644,283 |
|
0.29% Nasdaq 
Income Statement
